These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 30532098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA.
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [Abstract] [Full Text] [Related]

  • 3. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR, Tsai CL, Huang YY, Shiue CY, Tzen KY, Yen RF, Hsin LW.
    PLoS One; 2016 Jan; 11(9):e0161295. PubMed ID: 27612194
    [Abstract] [Full Text] [Related]

  • 4. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC, Lin KJ, Hsiao IT, Hsieh CJ, Lin WY, Lu CS, Wey SP, Yen TC, Kung MP, Weng YH.
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, Mentis MJ, Moeller JR, Eidelberg D.
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [Abstract] [Full Text] [Related]

  • 6. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ.
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography.
    Sanchez-Catasus CA, Bohnen NI, Yeh FC, D'Cruz N, Kanel P, Müller MLTM.
    J Nucl Med; 2021 Apr; 62(4):545-552. PubMed ID: 32859707
    [Abstract] [Full Text] [Related]

  • 8. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, Heumann M, Frey KA, Albin RL.
    J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
    [Abstract] [Full Text] [Related]

  • 9. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA.
    Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
    [Abstract] [Full Text] [Related]

  • 10. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
    Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ.
    Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
    [Abstract] [Full Text] [Related]

  • 11. [Not Available].
    Prange S, Hermier M, Danaila T, Laurencin C, Thobois S.
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [Abstract] [Full Text] [Related]

  • 12. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ.
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [Abstract] [Full Text] [Related]

  • 13. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR.
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [Abstract] [Full Text] [Related]

  • 14. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Blesa J, Juri C, Collantes M, Peñuelas I, Prieto E, Iglesias E, Martí-Climent J, Arbizu J, Zubieta JL, Rodríguez-Oroz MC, García-García D, Richter JA, Cavada C, Obeso JA.
    Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
    [Abstract] [Full Text] [Related]

  • 15. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Martin WR, Wieler M, Stoessl AJ, Schulzer M.
    Ann Neurol; 2008 Mar; 63(3):388-94. PubMed ID: 18240153
    [Abstract] [Full Text] [Related]

  • 16. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C, Peñuelas I, Obeso JA.
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [Abstract] [Full Text] [Related]

  • 17. Quantitative study of 18F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis.
    Jung Lung H, Weng YH, Wen MC, Hsiao IT, Lin KJ.
    Sci Rep; 2018 Oct 30; 8(1):16027. PubMed ID: 30375444
    [Abstract] [Full Text] [Related]

  • 18. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J.
    J Nucl Med; 2015 Feb 30; 56(2):234-42. PubMed ID: 25593112
    [Abstract] [Full Text] [Related]

  • 19. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.
    Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D.
    Lancet Neurol; 2010 Feb 30; 9(2):149-58. PubMed ID: 20061183
    [Abstract] [Full Text] [Related]

  • 20. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L, Kostic V, Sobic-Saranovic D, Stefanova E, Jecmenica-Lukic M, Jesic A, Stojiljkovic M, Odalovic S, Gallivanone F, Castiglioni I, Radovic B, Trajkovic G, Artiko V.
    Neurol Res; 2017 Aug 30; 39(8):675-684. PubMed ID: 28378615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.